AbbVie | ABBV - Market Capitalization

Stock Price
228.51
Daily Change
-0.97 -0.42%
Monthly
3.51%
Yearly
11.94%
Q1 Forecast
217.84

AbbVie reported $405.49B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Abbott USD 217.86B 15.25B Dec/2025
ALKERMES USD 5.65B 696M Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Coherus Biosciences USD 278M 184M Jun/2025
Eisai JPY 1.43T 119.2B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Infinity Pharmaceuticals USD 19M 5M Jun/2023
J&J USD 500.24B 67.44B Dec/2025
Medtronic USD 118.67B 10.66B Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026
Zoetis USD 57.53B 2.08B Feb/2026